Revolution Medicines RVMD Growth Metrics (2019-2026)

NASDAQ RVMD
$177.96 -11.30 (-5.97%)
At close: Oct 16, 2026 · 4:00 PM EDT
Reported Financials

Revolution Medicines Quarterly Growth Metrics

Periods 29 quarters
Latest Jun 2026

Revolution Medicines reported asset growth of 77.94% for the quarter ended Jun 2026. These growth metrics cover 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Growth MetricsGrowth Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Growth Ratios
Assets Growth (1y)
23.51%30.06%-15.88%-18.25%12.37%10.02%57.19%69.68%19.17%153.93%77.81%68.43%79.12%24.09%23.95%34.35%27.73%-7.97%-4.72%77.94%
Assets Growth (3y)
54.41%33.18%33.24%18.26%53.74%32.97%32.69%33.86%51.34%51.31%56.59%39.70%42.60%28.06%59.09%
Assets Growth (5y)
63.27%39.09%39.86%30.50%32.92%22.66%41.06%
Assets (QoQ)
-5.05%0.41%-7.48%-7.32%30.52%-1.69%32.18%0.04%-8.33%109.47%-7.44%-5.24%-2.51%45.11%-7.54%2.71%-7.31%4.56%-4.28%91.83%
Capital Expenditures Growth (1y)Capex Growth (1y)
-33.92%1.20%-47.22%92.53%676.43%143.11%-6.93%-55.70%-28.09%-19.44%80.15%114.39%38.86%-47.26%3.13%210.55%-4.86%57.53%-52.91%-69.32%
Capital Expenditures Growth (3y)Capex Growth (3y)
76.94%58.78%47.12%77.99%42.86%33.15%54.53%25.61%-3.99%22.28%97.92%1.09%20.02%43.41%-1.69%-12.53%-4.36%26.89%
Capital Expenditures Growth (5y)Capex Growth (5y)
56.16%30.62%26.03%19.10%40.20%73.49%37.28%10.49%-15.54%11.75%
Capital Expenditures (QoQ)Capex (QoQ)
-65.40%160.57%59.68%33.72%39.55%-18.41%-38.87%-36.35%126.54%-8.60%36.69%-24.25%46.73%-65.28%167.27%128.11%-55.05%-42.52%-20.10%48.63%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y)
99.09%4.06%-72.22%-45.92%38.55%48.77%337.43%259.54%100.29%331.29%-32.49%-27.51%-43.84%-21.99%15.64%45.96%8.04%-29.34%32.19%102.62%
Cash & Equivalents Growth (3y)Cash & Equiv. Growth (3y)
15.89%7.36%101.65%113.19%32.74%151.26%76.78%88.30%-6.39%12.12%15.94%71.06%50.59%56.11%6.71%33.47%1.06%28.95%
Cash & Equivalents Growth (5y)Cash & Equiv. Growth (5y)
35.67%26.39%55.94%100.74%12.80%75.79%27.37%29.77%4.63%33.05%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ)
-33.97%-15.99%-9.98%8.31%69.16%-9.80%164.68%-10.98%-5.77%94.24%-58.57%-4.41%-27.00%169.83%-38.58%20.65%-45.97%76.48%14.90%84.93%
Cash from Investing Activities Growth (1y)Cash from Investing Growth (1y)
70.11%-86.44%1,806.67%150.82%-309.05%-183.25%-90.92%-169.78%162.66%-5,254.76%-6,305.36%347.90%-127.75%-3.29%93.57%-68.25%215.74%119.06%1,182.29%-4,939.16%
Cash from Investing Activities Growth (3y)Cash from Investing Growth (3y)
96.97%46.05%-27.33%-42.37%27.38%31.67%40.38%-100.36%-378.26%42.26%10.73%-263.54%-33.18%-18.10%30.08%132.33%250.87%-236.47%
Cash from Investing Activities Growth (5y)Cash from Investing Growth (5y)
-114.15%31.48%18.53%-119.53%23.21%17.62%17.57%3.53%136.99%-68.32%
Cash from Investing Activities (QoQ)Cash from Investing (QoQ)
75.42%128.28%415.94%41.74%-297.81%94.24%156.25%-1,189.69%277.64%-591.78%34.81%143.53%-119.89%-1,730.09%95.94%314.91%-27.50%201.35%130.52%-1,060.91%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y)
-35.41%-56.85%-48.10%-63.48%-41.40%-57.36%-13.11%-20.47%-94.25%-95.12%-157.34%-90.95%-29.77%-14.70%-21.10%-73.02%-58.96%-98.31%-82.15%-74.66%
Cash from Operations Growth (3y)Cash from Ops. Growth (3y)
-63.57%-69.20%-55.14%-74.38%-30.59%-49.74%-54.94%-68.87%-62.75%-55.51%-52.76%-52.15%-52.19%-58.48%-58.83%-64.34%-78.39%-79.36%
Cash from Operations Growth (5y)Cash from Ops. Growth (5y)
-66.35%-61.96%-56.58%-64.01%-47.32%-61.81%-50.31%-61.41%-56.90%-62.60%
Cash from Operations (QoQ)Cash from Ops. (QoQ)
-7.36%-7.32%-40.48%-1.01%7.14%-19.43%-0.98%-7.58%-49.73%-19.97%-33.18%20.18%-1.76%-6.04%-40.60%-14.05%6.51%-32.28%-29.15%-9.36%
EBITDA Margin Growth (1y)
-0.45M-0.02M-0.04M-0.02M0.25M0.02M-0.03M-0.21M-2.36M
EBITDA Margin Growth (3y)
-0.07M-0.06M-0.21M-0.02M-0.09M-0.25M-2.37M
EBITDA Margin (QoQ)
-0.42M0.42M-0.02M0.01M-0.16M0.18M-0.07M-0.18M
EBIT Growth (1y)
-92.96%-55.26%-54.96%-39.42%-43.96%-16.62%-29.70%-75.23%-61.04%-191.67%-87.42%-43.98%-42.57%-20.18%-70.92%-68.99%-79.42%-67.18%-84.92%-90.82%
EBIT Growth (3y)
-77.08%-80.48%-78.05%-46.65%-52.76%-57.24%-64.77%-74.14%-55.59%-52.08%-48.96%-59.90%-60.76%-62.15%-60.30%-80.29%-80.94%-66.83%
EBIT Growth (5y)
-68.29%-71.49%-66.92%-61.71%-62.76%-56.74%-62.82%-60.38%-64.11%-62.53%
EBIT Margin Growth (1y)
-0.46M-0.02M-0.04M-0.02M0.25M0.02M-0.03M-0.22M-2.39M
EBIT Margin Growth (3y)
-0.07M-0.06M-0.22M-0.02M-0.09M-0.26M-2.39M
EBIT Margin (QoQ)
-0.43M0.43M-0.02M0.01M-0.16M0.19M-0.07M-0.18M
EBIT (QoQ)
-19.37%0.47%-9.52%-7.14%-23.26%19.37%-21.80%-44.76%-13.28%-46.03%21.74%-11.21%-12.17%-23.10%-11.30%-9.95%-19.10%-14.70%-23.12%-13.46%
EBT Growth (1y)
-94.48%-55.65%-55.07%-38.20%-39.07%-7.51%-18.13%-60.56%-52.53%-184.64%-70.35%-35.54%-39.17%-21.17%-83.97%-85.98%-95.28%-86.82%-112.64%-160.05%
EBT Growth (3y)
-78.53%-82.22%-79.09%-43.99%-49.96%-53.32%-60.38%-68.25%-46.13%-44.35%-43.45%-54.78%-54.70%-59.36%-60.64%-86.08%-88.18%-87.15%
EBT Growth (5y)
-62.84%-67.45%-64.90%-59.42%-60.25%-55.48%-62.16%-60.89%-64.94%-70.82%
EBT Margin Growth (1y)
-0.46M-0.02M-0.04M-0.02M0.26M0.02M-0.02M-0.19M-2.14M
EBT Margin Growth (3y)
-0.07M-0.06M-0.21M-0.02M-0.08M-0.23M-2.13M
EBT Margin (QoQ)
-0.43M0.43M-0.02M0.01M-0.15M0.18M-0.06M-0.16M
EBT (QoQ)
-19.51%0.50%-9.44%-6.20%-20.26%23.08%-20.25%-44.35%-14.25%-43.54%28.04%-14.85%-17.30%-24.98%-9.26%-16.11%-23.17%-19.56%-24.37%-41.99%
EPS (Basic) Growth (1y)
-72.17%-16.07%-47.48%-36.56%-20.26%3.13%7.62%-11.58%-14.65%-103.70%1.93%12.28%5.64%18.75%-61.08%-62.86%-72.18%-65.45%-101.96%-132.54%
EPS (Basic) Growth (3y)
42.01%41.55%45.53%50.65%-2.11%-25.87%-33.40%-31.82%-10.14%-10.16%-9.17%-17.04%-13.43%-16.82%-23.04%-39.90%-47.21%-49.22%
EPS (Basic) Growth (5y)
29.30%27.85%29.44%27.60%-10.96%-23.29%-30.99%-25.22%-34.16%-38.32%
EPS (Basic) (QoQ)
-19.29%-0.50%-7.44%-6.03%-5.05%19.05%-2.46%-28.07%-7.94%-43.82%50.67%-14.57%-16.11%-23.83%2.21%-15.84%-22.75%-18.99%-19.37%-33.37%
EPS (Diluted) Growth (1y)
-16.07%-14.74%-36.56%-20.26%3.13%7.62%-11.58%-14.65%-103.70%1.93%12.28%5.64%18.75%-61.08%-62.86%-72.18%-65.45%-101.96%-132.54%
EPS (Diluted) Growth (3y)
-31.82%-1.30%-10.16%-9.17%-17.04%-13.43%-16.82%-23.04%-39.90%-47.21%-49.22%
EPS (Diluted) Growth (5y)
-25.22%-27.59%-38.32%
EPS (Diluted) (QoQ)
-19.29%-0.50%-7.44%-6.03%-5.05%19.05%-2.46%-28.07%-7.94%-43.82%50.67%-14.57%-16.11%-23.83%2.21%-15.84%-22.75%-18.99%-19.37%-33.37%
FCF Margin Growth (1y)
-0.31M-0.01M-0.03M-0.02M0.17M576.00-0.02M-0.11M-1.61M
FCF Margin Growth (3y)
-0.07M-0.05M-0.15M-0.03M-0.07M-0.16M-1.63M
FCF Margin (QoQ)
-0.30M0.29M-0.03M0.01M-0.10M0.12M-0.05M-0.09M
Free Cash Flow Growth (1y)FCF Growth (1y)
-33.69%-54.36%-39.74%-64.56%-49.19%-59.87%-12.45%-17.17%-86.44%-90.03%-155.23%-91.33%-30.00%-13.54%-20.75%-75.55%-57.28%-97.95%-79.92%-69.98%
Free Cash Flow Growth (3y)FCF Growth (3y)
-63.95%-68.69%-54.57%-74.54%-30.87%-49.40%-54.93%-67.38%-58.88%-54.52%-53.49%-51.09%-51.33%-57.88%-56.21%-62.24%-77.00%-78.73%
Free Cash Flow Growth (5y)FCF Growth (5y)
-66.11%-60.83%-55.01%-62.90%-47.19%-62.12%-50.04%-60.16%-54.18%-61.56%
Free Cash Flow (QoQ)FCF (QoQ)
-4.66%-9.19%-41.04%-2.09%5.12%-17.01%0.80%-6.38%-50.98%-19.26%-33.24%20.25%-2.58%-4.16%-41.71%-15.94%8.09%-31.09%-28.80%-9.53%
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
93.04%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
27.00%55.72%58.41%58.91%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
90.96%-9.82%-20.48%41.81%
Net Cash Flow Growth (1y)NCF Growth (1y)
-262.48%-150.78%-104.38%105.20%210.10%12.37%2,554.39%-667.35%-130.25%2,030.45%-253.39%72.37%-237.01%1.25%48.61%643.30%-146.74%-51.46%127.30%441.95%
Net Cash Flow Growth (3y)NCF Growth (3y)
-16.61%-29.05%46.58%-50.28%16.99%33.68%-36.46%104.79%-53.95%56.64%-3.93%167.43%-168.45%104.21%-65.29%125.63%-40.08%116.41%
Net Cash Flow Growth (5y)NCF Growth (5y)
-126.56%-20.68%-3.22%132.77%-26.68%19.51%-45.41%33.38%-25.39%34.49%
Net Cash Flow (QoQ)NCF (QoQ)
57.41%69.89%45.86%174.92%801.65%-123.96%1,616.40%-117.32%51.92%1,628.82%-220.49%96.88%-486.48%559.30%-161.15%132.98%-366.35%190.36%-65.61%554.78%
Net Income Growth (1y)
-94.48%-54.01%-55.07%-38.20%-38.51%-7.27%-18.13%-60.56%-47.87%-185.87%-70.35%-35.54%-44.13%-20.45%-83.97%-85.98%-95.28%-87.54%-112.64%-160.05%
Net Income Growth (3y)
-78.53%-82.22%-78.85%-57.02%-51.67%-53.43%-58.52%-67.78%-46.13%-44.35%-43.45%-54.58%-54.70%-59.36%-60.86%-86.22%-88.18%-87.15%
Net Income Growth (5y)
-62.84%-67.45%-64.90%-67.87%-61.34%-55.54%-62.16%-60.55%-64.94%-70.82%
Net Income (QoQ)
-19.51%0.50%-9.44%-6.20%-19.78%22.94%-20.51%-44.35%-10.31%-48.97%28.19%-14.85%-17.30%-24.49%-9.69%-16.11%-23.17%-19.56%-24.37%-41.99%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y)
-94.48%-54.01%-55.07%-38.20%-38.51%-7.27%-18.13%-60.56%-47.87%-185.87%-70.35%-35.54%-44.13%-20.45%-83.97%-85.98%-95.28%-87.54%-112.64%-160.05%
Net Income towards Common Stockholders Growth (3y)Net Income Growth (3y)
-65.11%-66.84%-62.58%-44.20%-46.32%-53.43%-58.52%-67.78%-46.13%-44.35%-43.45%-54.58%-54.70%-59.36%-60.86%-86.22%-88.18%-87.15%
Net Income towards Common Stockholders Growth (5y)Net Income Growth (5y)
-55.38%-58.83%-55.73%-59.50%-57.91%-55.54%-62.16%-60.55%-64.94%-70.82%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ)
-19.51%0.50%-9.44%-6.20%-19.78%22.94%-20.51%-44.35%-10.31%-48.97%28.19%-14.85%-17.30%-24.49%-9.69%-16.11%-23.17%-19.56%-24.37%-41.99%
Net Margin Growth (1y)
-0.46M-0.02M-0.04M-0.02M0.26M0.02M-0.02M-0.19M-2.14M
Net Margin Growth (3y)
-0.07M-0.06M-0.20M-0.02M-0.08M-0.23M-2.14M
Net Margin (QoQ)
-0.43M0.43M-0.02M0.01M-0.15M0.18M-0.06M-0.16M
Operating Income Growth (1y)Op. Inc Growth (1y)
-92.96%-55.26%-54.96%-39.42%-43.96%-16.62%-29.70%-75.23%-61.04%-191.67%-87.42%-43.98%-42.57%-20.18%-70.92%-68.99%-79.42%-67.18%-84.92%-90.82%
Operating Income Growth (3y)Op. Inc Growth (3y)
-77.08%-80.48%-78.05%-46.65%-52.76%-57.24%-64.77%-74.14%-55.59%-52.08%-48.96%-59.90%-60.76%-62.15%-60.30%-80.29%-80.94%-66.83%
Operating Income Growth (5y)Op. Inc Growth (5y)
-68.29%-71.49%-66.92%-61.71%-62.76%-56.74%-62.82%-60.38%-64.11%-62.53%
Operating Income (QoQ)Op. Inc (QoQ)
-19.37%0.47%-9.52%-7.14%-23.26%19.37%-21.80%-44.76%-13.28%-46.03%21.74%-11.21%-12.17%-23.10%-11.30%-9.95%-19.10%-14.70%-23.12%-13.46%
Operating Margin Growth (1y)
-0.46M-0.02M-0.04M-0.02M0.25M0.02M-0.03M-0.22M-2.39M
Operating Margin Growth (3y)
-0.07M-0.06M-0.22M-0.02M-0.09M-0.26M-2.39M
Operating Margin (QoQ)
-0.43M0.43M-0.02M0.01M-0.16M0.19M-0.07M-0.18M
Profit After Tax Growth (1y)PAT Growth (1y)
-94.48%-54.01%-55.07%-38.20%-38.51%-7.27%-18.13%-60.56%-47.87%-185.87%-70.35%-35.54%-44.13%-20.42%-83.97%-85.98%-95.28%-87.58%-112.64%-160.05%
Profit After Tax Growth (3y)PAT Growth (3y)
-78.53%-82.22%-78.85%-43.89%-51.67%-53.43%-58.52%-67.78%-46.13%-44.35%-43.45%-54.57%-54.70%-59.36%-60.86%-86.22%-88.18%-87.15%
Profit After Tax Growth (5y)PAT Growth (5y)
-62.84%-67.45%-64.90%-59.29%-61.34%-55.54%-62.16%-60.55%-64.94%-70.82%
Profit After Tax (QoQ)PAT (QoQ)
-19.51%0.50%-9.44%-6.20%-19.78%22.94%-20.51%-44.35%-10.31%-48.97%28.19%-14.85%-17.30%-24.46%-9.71%-16.11%-23.17%-19.56%-24.37%-41.99%
Property, Plant & Equipment (Net) Growth (1y)PP&E (Net) Growth (1y)
43.67%29.68%20.01%48.08%80.74%61.63%41.97%23.93%11.05%22.54%27.84%28.23%22.32%6.23%14.58%30.71%32.69%36.66%15.92%4.72%
Property, Plant & Equipment (Net) Growth (3y)PP&E (Net) Growth (3y)
37.70%39.86%40.55%42.33%36.95%29.63%33.01%34.90%28.14%27.64%27.59%21.70%21.17%19.30%20.63%
Property, Plant & Equipment (Net) Growth (5y)PP&E (Net) Growth (5y)
27.72%32.00%36.01%36.16%30.11%23.67%26.36%
Property, Plant & Equipment (Net) (QoQ)PP&E (Net) (QoQ)
-5.93%14.22%13.10%21.86%14.81%2.15%-0.66%6.38%2.88%12.71%3.64%6.70%-1.86%-2.12%11.79%21.71%-0.37%0.81%-5.18%9.95%
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
-463.00-679.000.00M0.00M0.00M-497.00172.00653.00137.00172.00310.00-34.0045.0088.00-393.00-593.00-930.000.00M0.00M0.00M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-929.000.00M0.00M0.00M-615.00-991.00-941.00-237.0089.0026.00-748.000.00M0.00M0.00M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.00M0.00M0.00M0.00M0.00M0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-432.00-306.00-382.00-491.0055.00320.00288.00-10.00-461.00355.00426.00-354.00-382.00398.00-56.00-554.00-718.00-807.000.00M576.00
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-413.00-708.000.00M0.00M0.00M-632.0092.00568.00-108.00-120.00179.00-190.0010.0079.00-504.00-629.000.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-914.000.00M0.00M0.00M-956.000.00M0.00M-673.00-233.00-251.000.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
-486.00-373.00-414.00-611.002.00390.00310.00-134.00-674.00378.00609.00-503.00-473.00447.0026.00-628.00-894.00-924.000.00M0.00M
Return on Equity [ROE] Growth (1y)ROE Growth (1y)
-402.00-808.000.00M0.00M0.00M-624.00433.000.00M402.00363.00438.0041.00187.00144.00-485.000.00M0.00M0.00M-0.01M0.00M
Return on Equity [ROE] Growth (3y)ROE Growth (3y)
0.00M0.00M0.00M0.00M-625.000.00M0.00M-116.00387.00158.000.00M0.00M-0.01M-0.01M
Return on Equity [ROE] Growth (5y)ROE Growth (5y)
0.00M0.00M0.00M0.00M-0.01M-0.01M
Return on Equity [ROE] (QoQ)ROE (QoQ)
-518.00-467.00-583.00-678.00127.00510.00474.0019.00-601.00471.00549.00-378.00-456.00428.00-79.00-907.000.00M0.00M0.00M149.00
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.46M-0.02M-0.04M-0.02M0.25M0.02M-0.03M-0.22M0.09M-2.39M-1.10M-7.81M-8.66M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.07M-0.06M-0.22M-0.02M-0.09M-0.26M-0.12M-2.39M-1.17M-8.04M-8.32M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-1.20M-8.09M-8.79M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.43M0.43M-0.02M0.01M-0.16M0.19M-0.07M-0.18M0.14M-2.28M1.21M-6.89M-0.71M
Revenue Growth (1y)
-91.30%8.10%-25.20%4.81%204.81%62.05%-7.44%-58.05%-95.16%
Revenue Growth (3y)
-16.82%-9.46%-35.50%8.24%-15.31%-27.48%-56.07%
Revenue (QoQ)
-87.34%759.22%-19.89%20.30%-63.19%356.79%-54.25%-45.48%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y)
118.24%135.45%96.16%52.42%39.66%34.19%45.98%60.29%67.93%205.76%67.11%52.35%52.02%-11.75%54.76%45.79%48.15%50.17%248.03%132.40%
Share-based Compensation Growth (3y)Stock Comp. Growth (3y)
154.51%152.17%112.01%81.19%83.61%86.00%72.34%112.98%68.51%54.97%52.77%53.56%55.71%52.69%55.80%59.42%108.01%72.82%
Share-based Compensation Growth (5y)Stock Comp. Growth (5y)
109.36%108.24%89.33%74.22%74.13%70.23%63.06%66.52%91.53%66.01%
Share-based Compensation (QoQ)Stock Comp. (QoQ)
9.67%6.35%7.21%21.88%0.49%2.19%16.63%33.83%5.29%86.06%-36.26%22.01%5.06%8.01%11.79%14.93%6.76%9.48%159.08%-23.25%

Revolution Medicines Growth Metrics API

Pull Revolution Medicines's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RVMD&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY